What the content outline covers
The NBNSC CNSC Candidate Handbook lists these task statements for Clinical Management:
- Initiation: route and access; formulation, rate and volume; adjunct drugs; cost-effective choices; short- and long-term goals; tests and consults; starting, advancing and stopping therapy (T17 to T25)
- Monitoring: device position and function; tolerance; fluid status; adherence; complications; labs; metabolic response; device status; safety and product shortages; drug-nutrient interactions; formula stability (T26 to T36)
- Modification: changing therapy with the clinical picture; managing complications; reevaluating goals and adjunct drugs; transition and discontinuation; moving between care settings; education (T37 to T43)
High-yield areas
- PN arithmetic: dextrose, amino acid and lipid kcal, glucose infusion rate, peripheral osmolarity
- Enteral formula selection and goal rates, free water and protein modulars
- Critical care timing: early EN, when supplemental PN fits, protein targets
- Refeeding syndrome management and electrolyte replacement
- Calcium-phosphate compatibility, filters, hang times and lipid emulsion choice
- Catheter infection and occlusion, liver disease with long-term PN, short bowel syndrome
- Neonatal and pediatric PN dosing
How to study it
Work through the ASPEN critical care guidelines and safety papers with a calculator beside you. For each topic, do a set of calculation questions until the steps are automatic, then mixed vignettes that make you choose between EN and PN, gastric and postpyloric, standard and specialty formulas. Keep a list of every number you had to look up and review it daily in the last two weeks.
Free practice questions: clinical management
Five questions from the bank, each with the answer, a rationale for every option and its source. Commit to an answer before you open each explanation.
A 55-year-old woman has received teduglutide for 9 months and has reduced her PN from 6 to 4 nights/week. She feels well. In addition to fluid and PN reassessment, which laboratory monitoring does the teduglutide label call for during ongoing treatment?
Show answer and explanation
Answer: D. Bilirubin, AP, lipase and amylase about every 6 months
A (incorrect): These tests are not part of teduglutide monitoring. Neoplasia surveillance relies on scheduled colonoscopy and endoscopy, not tumor markers.
B (incorrect): Thyroid disease is not a labeled risk of teduglutide. Quarterly thyroid testing would not detect its known biliary and pancreatic adverse effects.
C (incorrect): Micronutrient status does need attention as PN is reduced, but weekly zinc and copper are not part of the label and are not a substitute for biliary and pancreatic monitoring.
D (correct): The label recommends bilirubin, alkaline phosphatase, lipase and amylase at baseline and about every 6 months, because gallbladder, biliary and pancreatic disease have been reported. Clinically meaningful rises call for imaging and reassessment of therapy.
Reference: Takeda Pharmaceuticals America. Teduglutide for injection, for subcutaneous use: prescribing information. DailyMed; revised 2025. Warnings and Precautions 5.3; Dosage and Administration 2.4. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66b69c1e-b25c-44d3-b5ff-1c1de9a516fa
A 56-year-old man develops a proximal jejunal enterocutaneous fistula, just beyond the ligament of Treitz, draining 1.2 L/day of bilious fluid after a small-bowel resection. He is kept NPO on PN, and losses will be replaced separately with IV fluid. Serum bicarbonate is 19 mEq/L and chloride 110 mEq/L. Which initial replacement fluid best matches the effluent?
Show answer and explanation
Answer: B. Lactated Ringer's solution
A (incorrect): 0.9% sodium chloride suits gastric losses, which are rich in hydrochloric acid. For a bicarbonate-rich proximal small-bowel effluent it adds chloride and worsens hyperchloremic acidosis.
B (correct): Lactated Ringer's solution is correct. A proximal jejunal fistula lies close to the ampulla of Vater and carries pancreatic and biliary fluid high in bicarbonate, so a balanced crystalloid containing a base is the more appropriate initial replacement, especially with his low bicarbonate and high chloride.
C (incorrect): 5% dextrose in water contains no sodium or base. Using it to replace an isotonic, sodium-rich effluent causes hyponatremia.
D (incorrect): 0.45% sodium chloride is hypotonic relative to pancreaticobiliary fluid (sodium about 135 to 145 mEq/L) and contains no base.
Reference: Kumpf VJ, Yeh DD. Use of parenteral nutrition in the management of enterocutaneous fistula. Nutr Clin Pract. 2025;40(1):64-75. Fluid and electrolyte requirements; Table 1 Composition of gastrointestinal secretions. https://pmc.ncbi.nlm.nih.gov/articles/PMC11713215/
A 54-year-old woman weighing 80 kg (BMI 28) is in the medical ICU with septic shock that has resolved. Her protein goal is set at 1.5 g/kg/day of actual body weight. She receives a 1.0 kcal/mL standard formula containing 55 g protein/L on a volume-based protocol of 1,500 mL/day, which meets her energy goal. Each packet of a liquid protein modular provides 15 g protein and 60 kcal. What is the minimum number of packets per day that meets her protein goal?
Show answer and explanation
Answer: B. 3 packets
Worked calculation
- Step 1: Protein goal = 1.5 g/kg x 80 kg = 120 g/day.
- Step 2: Formula protein = 1.5 L x 55 g/L = 82.5 g/day.
- Step 3: Gap = 120 - 82.5 = 37.5 g.
- Step 4: Packets = 37.5 / 15 = 2.5, rounded up to 3.
- Result: 3 packets (45 g) give 127.5 g/day.
A (incorrect): This answer comes from rounding 37.5 g / 15 g = 2.5 packets down instead of up. Two packets add only 30 g, leaving the patient at 112.5 g/day, below the 120 g goal.
B (correct): The goal is 120 g/day and the formula supplies 1.5 L x 55 g/L = 82.5 g, a gap of 37.5 g. Three 15-g packets (45 g) are the fewest that close it, bringing intake to 127.5 g/day; SCCM/ASPEN 2016 recommends ongoing evaluation of protein adequacy and 1.2 to 2.0 g/kg/day in critical illness.
C (incorrect): This answer treats the formula's 55 g protein per liter as if it were the daily protein delivered, ignoring that 1.5 L is infused. It would supply about 157 g/day, well above the stated goal, and adds unnecessary cost and kcal.
D (incorrect): This answer ignores the protein already supplied by the formula and divides the entire 120 g goal by 15 g. It would provide over 200 g/day and about 480 extra kcal.
Reference: McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211. Recommendations A4 and C4 (evaluate protein adequacy; 1.2-2.0 g/kg actual body weight per day). https://doi.org/10.1177/0148607115621863
A 59-year-old man in the medical ICU, now hemodynamically stable, has had 4 liquid stools a day for 2 days while receiving a standard fiber-free polymeric formula at goal through a nasogastric tube. Clostridioides difficile testing is negative, and his medication list has been reviewed with no likely cause found. There is no abdominal distension. What is the most appropriate change to his nutrition plan?
Show answer and explanation
Answer: A. Continue feeding and add soluble fiber
A (correct): SCCM/ASPEN suggests continuing EN while the cause is evaluated, and adding 10 to 20 g/day of fermentable soluble fiber, or considering a mixed fiber formula, when diarrhea persists in a stable patient. Peptide formulas are a later step if fiber fails or malabsorption is suspected.
B (incorrect): SCCM/ASPEN suggests that EN not be interrupted automatically for diarrhea. Holding feeds creates an energy and protein deficit without treating the cause.
C (incorrect): A small peptide formula is suggested for persistent diarrhea with suspected malabsorption or no response to fiber. Fiber has not yet been tried, and the peptide formula costs more.
D (incorrect): Cutting to 10 to 20 kcal/h would sharply reduce energy and protein delivery, and the guideline does not suggest this for diarrhea. The plan should address the diarrhea while keeping nutrition at goal.
Reference: McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40(2):159-211. Recommendations D6, E4b and F1 (continue EN while evaluating diarrhea; soluble fiber or mixed fiber formula for persistent diarrhea). https://doi.org/10.1177/0148607115621863
A 70-year-old woman with an enterocutaneous fistula that has now closed receives PN providing 1,700 kcal/day, which equals her energy goal. EN with a 1.2 kcal/mL formula was started 2 days ago and is tolerated at 30 mL/h continuously over 24 hours, with plans to advance by 10 mL/h every 12 hours as tolerated. PN has not yet been changed. Which PN adjustment is most appropriate today?
Show answer and explanation
Answer: B. Cut PN energy to about 840 kcal/day so the total approximates goal
Worked calculation
- Step 1: EN energy = 30 mL/h x 24 h x 1.2 kcal/mL = 864 kcal/day.
- Step 2: EN share of goal = 864 / 1,700 = 51%.
- Step 3: Total delivered = 1,700 + 864 = 2,564 kcal/day = 151% of goal.
- Step 4: PN energy needed to complement EN = 1,700 - 864 = 836 kcal/day, about 840 kcal/day.
- Result: reduce PN energy to about 840 kcal/day.
A (incorrect): Leaving PN unchanged delivers about 2,560 kcal/day, roughly 150% of goal. The guideline specifically advises lowering PN energy as EN increases to prevent overfeeding during the transition.
B (correct): EN supplies 51% of the goal, below the 60% level at which SCCM/ASPEN suggests stopping PN, so PN is still needed. The guideline rationale calls for reducing PN energy to compensate for the energy delivered enterally to avoid overfeeding; 1,700 minus 864 kcal leaves about 840 kcal/day for PN.
C (incorrect): EN currently provides only about half of the energy goal, so stopping PN today would drop her to roughly 51% of her needs. The guideline stops PN only once EN exceeds 60% of target; until then PN is reduced to complement what EN delivers.
D (incorrect): Holding tolerated EN reverses the transition and gives up the benefits of enteral feeding. The goal is to advance EN while reducing PN, not to wean PN first.
Reference: Taylor BE, McClave SA, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). Crit Care Med. 2016;44(2):390-438. Section H, Recommendation H7 and rationale. https://doi.org/10.1097/CCM.0000000000001525
For exam preparation only, not clinical advice.
Practice 460+ clinical management questions, and the other three domains
Get 550+ practice questions across all four domains, a timed full-length mock (250 questions in 4 hours) or half-length mock (125 in 2 hours), worked steps for every calculation, and a rationale with its source for every answer, backed by a pass-or-refund guarantee. $199 USD, one time.
See the full question bankOne-time purchase · No subscription · Pass-or-refund guarantee
Other content domains
- Nutrition Assessment (31%)
- Professional Practice (7%)
- Process Management (5%)